Medindia

X

Alembic Settles Dementia Drug Patent Dispute With Novartis

by Kathy Jones on  June 16, 2012 at 10:35 PM Medico Legal News   - G J E 4
Indian drug maker Alembic Pharmaceuticals revealed that it has settled a patent case with Novartis over Rivastigmine Tartrate capsules which are used in treating dementia.
 Alembic Settles Dementia Drug Patent Dispute With Novartis
Alembic Settles Dementia Drug Patent Dispute With Novartis
Advertisement

The company said that it had partnered an American company, Breckenridge Pharmaceuticals, in settling the Paragraph IV patent litigation with Novartis.

Advertisement
Following this settlement, Alembic Pharmaceuticals said Novartis has given them the license to market the generic version of capsules before the date of the patent expiry.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All